|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of ABCA1 mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
|
|
G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
increases expression increases activity
|
EXP
|
Monocrotophos results in increased expression of ACACA mRNA Monocrotophos results in increased activity of ACACA protein
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
|
|
G
|
Ache
|
acetylcholinesterase
|
multiple interactions decreases activity decreases expression
|
ISO EXP
|
asoxime chloride inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; HLo 7 inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein] [Dichlorvos co-treated with Monocrotophos] results in increased activity of ACHE protein; [Monocrotophos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [sodium arsenite co-treated with Dichlorvos co-treated with Monocrotophos] results in decreased activity of ACHE protein Monocrotophos results in decreased expression of ACHE mRNA
|
CTD |
PMID:8783813 PMID:15679473 PMID:15793557 PMID:19730754 PMID:20026515 PMID:20728503 PMID:21349312 PMID:22285544 PMID:22903060 PMID:32207356 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
decreases expression
|
EXP
|
Monocrotophos results in decreased expression of ADIPOQ protein
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
affects expression multiple interactions increases expression
|
ISO
|
Monocrotophos affects the expression of AHR protein [Monocrotophos co-treated with Cimetidine] results in increased expression of AHR protein; [Rifampin co-treated with Monocrotophos] results in decreased expression of AHR mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of AHR protein Monocrotophos results in increased expression of AHR mRNA
|
CTD |
PMID:22733800 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
multiple interactions decreases expression
|
ISO
|
Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] Monocrotophos results in decreased expression of AIFM1 protein
|
CTD |
PMID:33078895 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
|
|
G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
multiple interactions increases expression
|
ISO
|
Monocrotophos results in increased expression of and affects the localization of APEX1 protein Monocrotophos results in increased expression of APEX1 mRNA
|
CTD |
PMID:28887667 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP
|
Monocrotophos results in increased expression of and affects the localization of BAX protein; resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX mRNA]; resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX protein] Monocrotophos results in increased expression of BAX mRNA; Monocrotophos results in increased expression of BAX protein
|
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bbc3
|
Bcl-2 binding component 3
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of BBC3 mRNA
|
CTD |
PMID:20957986 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
|
|
G
|
Bche
|
butyrylcholinesterase
|
decreases activity
|
EXP
|
Monocrotophos results in decreased activity of BCHE protein
|
CTD |
PMID:19730754 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression decreases expression multiple interactions
|
EXP
|
Monocrotophos results in increased expression of BCL2 mRNA; Monocrotophos results in increased expression of BCL2 protein Monocrotophos results in decreased expression of BCL2 mRNA; Monocrotophos results in decreased expression of BCL2 protein resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]; resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein]
|
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Bcl2l2
|
Bcl2-like 2
|
decreases expression
|
EXP
|
Monocrotophos results in decreased expression of BCL2L2 mRNA; Monocrotophos results in decreased expression of BCL2L2 protein
|
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:28,356,807...28,361,624
|
|
G
|
Casp3
|
caspase 3
|
increases expression multiple interactions
|
EXP
|
Monocrotophos results in increased expression of CASP3 mRNA; Monocrotophos results in increased expression of CASP3 protein; Monocrotophos results in increased expression of CASP3 protein modified form resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 mRNA]; resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 protein]
|
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp9
|
caspase 9
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of CASP9 mRNA; Monocrotophos results in increased expression of CASP9 protein; Monocrotophos results in increased expression of CASP9 protein modified form
|
CTD |
PMID:20957986 PMID:21445290 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
decreases activity
|
EXP
|
Monocrotophos results in decreased activity of CAT protein
|
CTD |
PMID:22751200 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of CDKN1A mRNA; Monocrotophos results in increased expression of CDKN1A protein
|
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
multiple interactions decreases expression
|
EXP
|
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of COX4I1 mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:48,721,199...48,727,921
|
|
G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
EXP
|
Monocrotophos results in increased expression of and affects the localization of CYCS protein
|
CTD |
PMID:20957986 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression increases activity multiple interactions
|
EXP ISO
|
Monocrotophos results in increased expression of CYP1A1 protein Monocrotophos results in increased activity of CYP1A1 protein Monocrotophos results in increased expression of CYP1A1 mRNA; Monocrotophos results in increased expression of CYP1A1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP1A1 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP1A1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 protein
|
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of CYP1A2 protein
|
CTD |
PMID:21445290 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G
|
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of CYP2B2 protein
|
CTD |
PMID:21445290 |
|
NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566
|
|
G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity multiple interactions increases expression
|
ISO
|
Monocrotophos results in increased activity of CYP2B6 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2B6 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 protein Monocrotophos results in increased expression of CYP2B6 mRNA; Monocrotophos results in increased expression of CYP2B6 protein
|
CTD |
PMID:22733800 |
|
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
increases expression increases activity multiple interactions
|
EXP ISO
|
Monocrotophos results in increased expression of CYP2E1 protein Monocrotophos results in increased activity of CYP2E1 protein Monocrotophos results in increased expression of CYP2E1 mRNA; Monocrotophos results in increased expression of CYP2E1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2E1 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2E1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 protein
|
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases activity increases expression multiple interactions
|
ISO
|
Monocrotophos results in increased activity of CYP3A4 protein Monocrotophos results in increased expression of CYP3A4 mRNA; Monocrotophos results in increased expression of CYP3A4 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 protein
|
CTD |
PMID:22733800 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of CYP7A1 mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of DGAT1 mRNA
|
CTD |
PMID:32207356 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:108,218,524...108,234,299
|
|
G
|
Fasn
|
fatty acid synthase
|
increases activity increases expression
|
EXP
|
Monocrotophos results in increased activity of FASN protein Monocrotophos results in increased expression of FASN mRNA
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of FOS protein
|
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
affects activity multiple interactions increases activity
|
EXP
|
Monocrotophos affects the activity of G6PD protein [Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein Monocrotophos results in increased activity of G6PD protein
|
CTD |
PMID:24248738 PMID:32207356 PMID:32267039 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
increases activity
|
EXP
|
Monocrotophos results in increased activity of GAPDH protein
|
CTD |
PMID:32207356 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
|
|
G
|
Gck
|
glucokinase
|
increases activity
|
EXP
|
Monocrotophos results in increased activity of GCK protein
|
CTD |
PMID:32267039 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
decreases activity affects activity multiple interactions
|
EXP
|
Monocrotophos results in decreased activity of GSR protein Monocrotophos affects the activity of GSR protein [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein
|
CTD |
PMID:22751200 PMID:24248738 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G
|
Gstp1
|
glutathione S-transferase pi 1
|
increases expression multiple interactions
|
EXP ISO
|
Monocrotophos results in increased expression of GSTP1 mRNA; Monocrotophos results in increased expression of GSTP1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of GSTP1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 protein
|
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of HMGCR mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
|
|
G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Monocrotophos results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G
|
Ins1
|
insulin 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of INS1 protein
|
CTD |
PMID:32207356 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
EXP ISO
|
Monocrotophos results in increased expression of JUN protein Monocrotophos results in increased expression of and results in increased phosphorylation of JUN protein
|
CTD |
PMID:20957986 PMID:21445290 PMID:28887667 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of LDLR mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
|
|
G
|
Lep
|
leptin
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of LEP protein
|
CTD |
PMID:32207356 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G
|
Lig3
|
DNA ligase 3
|
increases expression
|
ISO
|
Monocrotophos results in increased expression of LIG3 mRNA
|
CTD |
PMID:28887667 |
|
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G
|
Lpin1
|
lipin 1
|
increases activity affects expression
|
EXP
|
Monocrotophos results in increased activity of LPIN1 protein Monocrotophos affects the expression of LPIN1 mRNA
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G
|
Lpl
|
lipoprotein lipase
|
increases expression decreases activity
|
EXP
|
Monocrotophos results in increased expression of LPL mRNA Monocrotophos results in decreased activity of LPL protein
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
|
|
G
|
Maoa
|
monoamine oxidase A
|
decreases activity
|
EXP
|
Monocrotophos results in decreased activity of MAOA protein
|
CTD |
PMID:12018584 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593
|
|
G
|
Maob
|
monoamine oxidase B
|
decreases activity
|
EXP
|
Monocrotophos results in decreased activity of MAOB protein
|
CTD |
PMID:12018584 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:5,907,266...6,011,003
|
|
G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
decreases expression
|
EXP
|
Monocrotophos results in decreased expression of MCL1 mRNA; Monocrotophos results in decreased expression of MCL1 protein
|
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
|
|
G
|
Mt-nd1
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
|
multiple interactions decreases expression
|
EXP
|
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND1 mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G
|
Mt-nd2
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
|
decreases expression multiple interactions
|
EXP
|
Monocrotophos results in decreased expression of ND2 mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND2 mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G
|
Nes
|
nestin
|
decreases expression increases expression
|
ISO
|
Monocrotophos results in decreased expression of NES mRNA Monocrotophos results in increased expression of NES protein
|
CTD |
PMID:33569802 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Monocrotophos results in increased expression of NFE2L2 protein Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] Monocrotophos results in decreased expression of NFE2L2 mRNA
|
CTD |
PMID:28887667 PMID:33078895 PMID:35403558 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
affects expression multiple interactions
|
ISO
|
Monocrotophos affects the expression of NR1I2 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I2 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I2 protein
|
CTD |
PMID:22733800 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
multiple interactions decreases expression increases expression
|
ISO
|
[Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I3 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 protein Monocrotophos results in decreased expression of NR1I3 protein Monocrotophos results in increased expression of NR1I3 mRNA; Monocrotophos results in increased expression of NR1I3 protein
|
CTD |
PMID:22733800 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906
|
|
G
|
Nrf1
|
nuclear respiratory factor 1
|
multiple interactions decreases expression
|
EXP
|
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
decreases expression
|
ISO
|
Monocrotophos results in decreased expression of OGG1 mRNA
|
CTD |
PMID:28887667 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases expression
|
ISO
|
Monocrotophos results in increased expression of PARP1 mRNA; Monocrotophos results in increased expression of PARP1 protein
|
CTD |
PMID:28887667 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
decreases expression
|
EXP
|
Monocrotophos results in decreased expression of PPARA mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of PPARG mRNA
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression multiple interactions
|
EXP
|
Monocrotophos results in decreased expression of PPARGC1A mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of PPARGC1A mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G
|
Scarb1
|
scavenger receptor class B, member 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of SCARB1 mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:31,296,156...31,362,647
|
|
G
|
Sod2
|
superoxide dismutase 2
|
decreases expression multiple interactions
|
EXP
|
Monocrotophos results in decreased expression of SOD2 mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of SOD2 mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of SREBF1 mRNA
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of SREBF2 mRNA
|
CTD |
PMID:32267039 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
|
|
G
|
Tac1
|
tachykinin, precursor 1
|
multiple interactions
|
ISO
|
[perfluorooctanoic acid co-treated with Monocrotophos] results in decreased expression of TAC1 mRNA
|
CTD |
PMID:33569802 |
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
|
|
G
|
Tfam
|
transcription factor A, mitochondrial
|
multiple interactions decreases expression
|
EXP
|
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of TFAM mRNA]
|
CTD |
PMID:35403558 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
|
|
G
|
Th
|
tyrosine hydroxylase
|
multiple interactions increases activity
|
EXP
|
Mifepristone inhibits the reaction [Monocrotophos results in increased activity of TH protein]
|
CTD |
PMID:22305719 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of TNF protein
|
CTD |
PMID:32207356 PMID:32267039 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
EXP
|
Monocrotophos results in increased expression of TP53 mRNA; Monocrotophos results in increased expression of TP53 protein; Monocrotophos results in increased expression of TRP53 mRNA; Monocrotophos results in increased expression of TRP53 protein
|
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|